Stay updated on Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check3 days agoChange DetectedAdded a Locations section with the Iowa site details. Removed the Iowa Locations block and the HHS Vulnerability Disclosure link, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history updated: added Revision: v3.3.2 and removed Revision: v3.2.0.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding lapse notice banner that warned users about possible delays and operating status changes. The banner previously conveyed site-wide operational information.SummaryDifference0.4%

- Check53 days agoChange DetectedNo additions or deletions were detected for the study page (NCT03957551) in the provided screenshots and text; the page content appears unchanged.SummaryDifference0.5%

- Check82 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check89 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.